IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Skyepharma PLC

5 Dec 2005 15:08

HBM BioVentures (Cayman) Ltd05 December 2005 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) HBM BIOVENTURES (CAYMAN) LTD Company dealt in SKYEPHARMA PLC Class of relevant securityto which the dealings being disclosed relate (Note 2) ORDINARY SHARES Date of dealing 2 DECEMBER 2005 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 63,780,450 (8.46%)(2) Derivatives (other than options) NA (3) Options and agreements to purchase/sell NA Total 63,780,450 (8.46%) (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5)PURCHASE (02.12.2005) 3,003,923 0.523042SALE N/A N/A (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities(i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneyname, selling, securities price American, date paid/e.g. purchasing, to which European received call varying etc. the option etc. per unit option relates (Note 5) (Note 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit call option (Note 5) (d) Other dealings (including new securities)(Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 05 DECEMBER 2005 Contact name JOHN ARNOLD Telephone number +1 345 946 8002 If a connected EFM, name of offeree/offeror with which connected NA If a connected EFM, state nature of connection (Note 10) NA Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Jan 200711:07 amRNSNotification of Shares
3rd Jan 20074:02 pmRNSShare Purchase Plan
28th Dec 200611:39 amRNSNotification of Shares
27th Dec 20067:01 amRNSGBP35million Fundraising
19th Dec 20063:40 pmRNSMajor Interest in Shares
18th Dec 200612:00 pmRNSTransparency Directive
18th Dec 20067:02 amRNSFDA Approves Certihaler
30th Nov 20063:24 pmRNSMarket Maker Holding - Amend
30th Nov 200611:30 amRNSMarket Maker Holding
30th Nov 200611:03 amRNSShare Purchase Plan
27th Nov 200612:09 pmRNSNotification of Shares
24th Nov 200610:24 amRNSNotification of Interests
22nd Nov 20067:02 amRNSNotification of Interests
20th Nov 20067:02 amRNSPresentation at Conference
14th Nov 20067:03 amRNSBoard Appointment
7th Nov 20067:01 amRNSPositive Flutiform Update
2nd Nov 20064:13 pmRNSShare Purchase Plan
27th Oct 20062:26 pmRNSNotification of Shares
25th Oct 20067:01 amRNSNotification of Shares
24th Oct 20067:01 amRNSNDA for Zileuton CR
20th Oct 20067:00 amRNSNotification of Interest
9th Oct 200612:13 pmRNSCompany Secretary Appointment
4th Oct 20065:22 pmRNSDirector Shareholding
4th Oct 20067:01 amRNSPositive Data & EU Filing
28th Sep 20067:03 amRNSInterim Results
22nd Sep 200610:19 amRNSPersonnel Changes
6th Sep 20067:03 amRNSEuropean Flutiform Deal
5th Sep 20069:00 amRNSNotice of Results
31st Aug 200611:20 amRNSShare Purchase Plan
21st Aug 20067:01 amRNSAppointment of Auditor
11th Aug 20067:01 amRNSRe: Share Price Movement
8th Aug 20062:45 pmRNSAdviser Update
4th Aug 20065:02 pmRNSNotification of Shares
1st Aug 20065:34 pmRNSShare Purchase Plan
1st Aug 20062:00 pmRNSFDA Filing
28th Jul 200612:00 pmRNSNASDAQ for Compliance
17th Jul 20064:36 pmRNSPrice Monitoring Extension
10th Jul 200612:11 pmRNSNotification of Shares
4th Jul 20064:32 pmRNSShare Purchase Plan
30th Jun 200611:15 amRNSRe: DepoBupivacaine Rights
28th Jun 200611:32 amRNSAGM Statement
23rd Jun 20067:01 amRNSConference Presentation
21st Jun 20067:01 amRNSBusiness Review
15th Jun 20061:50 pmRNSNotification of Shares
12th Jun 20062:41 pmRNSRe Convertible Bonds
31st May 20065:44 pmRNSShare Purchase Plan
31st May 20069:08 amRNSAsco Presentation
22nd May 20067:00 amRNSFirst Horizon Deal
19th May 20063:05 pmRNSDirector Declaration
17th May 20069:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.